Literature DB >> 26303209

How does batf3 determine dendritic cell development?

Ken Shortman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26303209     DOI: 10.1038/icb.2015.69

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


× No keyword cloud information.
  15 in total

1.  Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset.

Authors:  Shinji Kasahara; Edward A Clark
Journal:  J Leukoc Biol       Date:  2011-12-06       Impact factor: 4.962

2.  Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes.

Authors:  Shalin H Naik; Donald Metcalf; Annemarie van Nieuwenhuijze; Ian Wicks; Li Wu; Meredith O'Keeffe; Ken Shortman
Journal:  Nat Immunol       Date:  2006-05-07       Impact factor: 25.606

3.  Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow.

Authors:  Nobuyuki Onai; Aya Obata-Onai; Michael A Schmid; Toshiaki Ohteki; David Jarrossay; Markus G Manz
Journal:  Nat Immunol       Date:  2007-10-07       Impact factor: 25.606

4.  Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.

Authors:  Irina Caminschi; David Vremec; Fatma Ahmet; Mireille H Lahoud; Jose A Villadangos; Kenneth M Murphy; William R Heath; Ken Shortman
Journal:  Mol Immunol       Date:  2011-12-29       Impact factor: 4.407

Review 5.  Development of antigen cross-presentation capacity in dendritic cells.

Authors:  Christiane Dresch; Yann Leverrier; Jacqueline Marvel; Ken Shortman
Journal:  Trends Immunol       Date:  2012-06-05       Impact factor: 16.687

6.  In vivo analysis of dendritic cell development and homeostasis.

Authors:  Kang Liu; Gabriel D Victora; Tanja A Schwickert; Pierre Guermonprez; Matthew M Meredith; Kaihui Yao; Fei-Fan Chu; Gwendalyn J Randolph; Alexander Y Rudensky; Michel Nussenzweig
Journal:  Science       Date:  2009-03-12       Impact factor: 47.728

Review 7.  Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny.

Authors:  Martin Guilliams; Florent Ginhoux; Claudia Jakubzick; Shalin H Naik; Nobuyuki Onai; Barbara U Schraml; Elodie Segura; Roxane Tussiwand; Simon Yona
Journal:  Nat Rev Immunol       Date:  2014-07-18       Impact factor: 53.106

8.  CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.

Authors:  Cyril Seillet; Jacob T Jackson; Kate A Markey; Hugh J M Brady; Geoffrey R Hill; Kelli P A Macdonald; Stephen L Nutt; Gabrielle T Belz
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

9.  Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.

Authors:  Kai Hildner; Brian T Edelson; Whitney E Purtha; Mark Diamond; Hirokazu Matsushita; Masako Kohyama; Boris Calderon; Barbara U Schraml; Emil R Unanue; Michael S Diamond; Robert D Schreiber; Theresa L Murphy; Kenneth M Murphy
Journal:  Science       Date:  2008-11-14       Impact factor: 47.728

10.  Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.

Authors:  Gary E Grajales-Reyes; Arifumi Iwata; Jörn Albring; Xiaodi Wu; Roxane Tussiwand; Wumesh Kc; Nicole M Kretzer; Carlos G Briseño; Vivek Durai; Prachi Bagadia; Malay Haldar; Jörg Schönheit; Frank Rosenbauer; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2015-06-08       Impact factor: 25.606

View more
  2 in total

1.  Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.

Authors:  Tian-Tian Liu; Sunkyung Kim; Pritesh Desai; Do-Hyun Kim; Xiao Huang; Stephen T Ferris; Renee Wu; Feiya Ou; Takeshi Egawa; Steven J Van Dyken; Michael S Diamond; Peter F Johnson; Masato Kubo; Theresa L Murphy; Kenneth M Murphy
Journal:  Nature       Date:  2022-06-22       Impact factor: 69.504

Review 2.  Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment.

Authors:  Maureen L Drakes; Patrick J Stiff
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.